These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1701816)

  • 41. Antibacterial effect of bovine milk antibody against Escherichia coli in a mouse indigenous infection model.
    Nomoto K; Matsuoka Y; Hayakawa K; Ohwaki M; Kan T; Yoshikai Y; Nomoto K
    Med Microbiol Immunol; 1992; 181(2):87-98. PubMed ID: 1406460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recombinant Iss as a potential vaccine for avian colibacillosis.
    Lynne AM; Kariyawasam S; Wannemuehler Y; Johnson TJ; Johnson SJ; Sinha AS; Lynne DK; Moon HW; Jordan DM; Logue CM; Foley SL; Nolan LK
    Avian Dis; 2012 Mar; 56(1):192-9. PubMed ID: 22545546
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protective effects of polyclonal sera and of monoclonal antibodies active to Salmonella minnesota Re595 lipopolysaccharide during experimental endotoxemia.
    Nys M; Cloes JM; Demonty J; Joassin L
    J Infect Dis; 1990 Nov; 162(5):1087-95. PubMed ID: 1700024
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Immunity of the skin--infection and percutaneous immunization of rabbits with E. coli ATCC 13676].
    Hammerschmidt W; Hellmann E
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Apr; 259(2):252-67. PubMed ID: 3892981
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Minimal concentration of human IgM and IgG antibodies necessary to protect mice from challenges with live O6 Escherichia coli.
    Massironi SM; Arslanian C; Carneiro-Sampaio MM; Pontes GN
    FEMS Immunol Med Microbiol; 2011 Nov; 63(2):193-201. PubMed ID: 22077222
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cross-reactivity of monoclonal antibodies to Escherichia coli J5 with heterologous gram-negative bacteria and extracted lipopolysaccharides.
    Aydintug MK; Inzana TJ; Letonja T; Davis WC; Corbeil LB
    J Infect Dis; 1989 Nov; 160(5):846-57. PubMed ID: 2681436
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains.
    Lásaro MO; Luiz WB; Sbrogio-Almeida ME; Nishimura LS; Guth BE; Ferreira LC
    Infect Immun; 2004 Nov; 72(11):6480-91. PubMed ID: 15501779
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential effects of two different routes of immunization on protection against gram-negative sepsis by a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine in a burned mouse model.
    Neely AN; Bhattacharjee AK; Babcock GF; Holder IA; Cross AS
    J Burn Care Rehabil; 2002; 23(5):333-40. PubMed ID: 12352135
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-capsular antibodies activate killing of Escherichia coli O8:K87 by the alternate complement pathway in porcine serum.
    Clark NM; Berberov EM; Wang M; Moxley RA
    Vet Immunol Immunopathol; 2006 Nov; 114(1-2):185-91. PubMed ID: 16919781
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protective capacity of antibodies to outer-membrane components of Escherichia coli in a systemic mouse peritonitis model.
    Vuopio-Varkila J; Karvonen M; Saxén H
    J Med Microbiol; 1988 Feb; 25(2):77-84. PubMed ID: 2448461
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunization of mice with live oral vaccine based on a Salmonella enterica (sv Typhimurium) aroA strain expressing the Escherichia coli O111 O antigen.
    Wang L; Curd H; Reeves PR
    Microb Pathog; 1999 Jul; 27(1):55-9. PubMed ID: 10371709
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The virulence for mice of strains of Escherichia coli related to the effects of K antigens on their resistance to phagocytosis and killing by complement.
    Howard CJ; Glynn AA
    Immunology; 1971 May; 20(5):767-77. PubMed ID: 4950867
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Specific and Nonspecific immunity to Serratia marcescens infection.
    Simberkoff MS; Moldover NH; Rahal JJ
    J Infect Dis; 1976 Oct; 134(4):348-53. PubMed ID: 789788
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Immunization with targeted fusion anticaries DNA vaccine via intramuscular route:experiment with murine].
    Yu F; Fan MW; Xu QA; Jia R; Guo JH; Bian Z; Chen Z; Peng B; Fan B
    Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):754-9. PubMed ID: 15200917
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protective effects of murine monoclonal antibodies in experimental septicemia: E. coli antibodies protect against different serotypes of E. coli.
    Salles MF; Mandine E; Zalisz R; Guenounou M; Smets P
    J Infect Dis; 1989 Apr; 159(4):641-7. PubMed ID: 2647860
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-idiotypic immunization provides protection against lethal endotoxaemia in BALB/c mice.
    Cornelissen JJ; Maassen K; van Emst L; Weers PM; Harmsen M; Benaissa-Trouw BJ; Oosterlaken TA; Kraaijeveld CA; Verhoef J
    Immunology; 1993 Aug; 79(4):673-80. PubMed ID: 8406595
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bovine natural antibodies in antibody-dependent bactericidal activity against Escherichia coli and Salmonella Typhimurium and risk of mastitis.
    van Altena SE; Peen MA; van der Linden FH; Parmentier HK; Savelkoul HF; Tijhaar EJ
    Vet Immunol Immunopathol; 2016 Mar; 171():21-7. PubMed ID: 26964714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Production and characterisation of mouse monoclonal antibodies reacting with the lipopolysaccharide core region of gram-negative bacilli.
    Appelmelk BJ; Verweij-van Vught AM; Maaskant JJ; Schouten WF; De Jonge AJ; Thijs LG; Maclaren DM
    J Med Microbiol; 1988 Jun; 26(2):107-14. PubMed ID: 2455054
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae.
    Tobias J; Lebens M; Bölin I; Wiklund G; Svennerholm AM
    Vaccine; 2008 Feb; 26(6):743-52. PubMed ID: 18191006
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro evaluation of synergistic activity between ciprofloxacin and broad snouted caiman serum against Escherichia coli.
    Siroski PA; Russi NB; Ortega HH; Formentini EA
    Res Vet Sci; 2015 Feb; 98():98-105. PubMed ID: 25468795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.